Filed before 2025Filed 3 October 2023
Euphrates Vascular, Inc. has sold $9.08M so far
Euphrates Vascular, Inc., a biotech company based in St. Louis, MO, has sold $9.08M so far in its equity round, according to a filing dated 3 October 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 3 October 2023
- First filed
- 1 June 2021
- Round
- Equity round (amended filing)
- Amount sold
- $9.08M
- Offering size
- $9.08M
- Investors so far
- 33
- Based in
- St. Louis, MO
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 60% of the 1,396 tracked raises with an amount filed in 2023, and than 45% of the 142 in biotech.
Euphrates Vascular, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 3 Oct 2023 | Amended filing | $9.08M | This raise |
| 17 Sep 2018 | New filing | $590K | Another raise |
More with Cultivation Capital Life Sciences on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.